Digital tech became a major healthcare tool during the pandemic. And AI-powered prescription drug apps are leading the charge in …
Underserved communities are at higher risk for COVID, but they’re getting vaccinated at a slower pace. How do we correct a health…
Congress may soon revisit legislation to tackle the high costs of prescription drugs under Medicare. But drug pricing is never a …
Vaccine distribution is off to a rocky start. While some states are exceeding expectations, others continue to lag behind. This w…
With the new Hospital Price Transparency rule, patients will finally be able to view and compare the costs of services across hos…
Democrats soon will control Congress and the White House. What should patients with chronic conditions expect from a federal gove…
Congress and the new Biden White House are ready to hit the ground running in 2021. So we’re here to make sure patient needs are …
The Most Favored Nation Rule will take effect on January 1st. It’s bad news for Medicare infusion patients and providers, but the…
Navigating the legal issues that come with a cancer diagnosis is challenging. From employer discrimination to financial toxicity,…
As President-elect Joe Biden makes his health team picks, we discuss what patients may expect out of a new Democratic Administrat…
Can Republicans and Democrats work together to help the chronic disease community? Former FDA Commissioner Dr. Mark McClellan pre…
In the wake of Alex Trebek’s passing, we take a look at the state of pancreatic cancer treatments and care. Julie Fleshman, CEO o…
Precision medicine is revolutionizing cancer care. Dr. Razelle Kurzrock highlights how personalized treatments improve patient ou…
Power to patients! A new price transparency rule from the U.S. Department of Health and Human Services will allow you to see exac…
As a heated election season wraps up, Terry and Dr. Bob examine the latest results and what they mean for patients and federal he…
Gene therapies can be lifesaving for many patients. But accessing them can be a challenge of its own. Terry and Dr. Bob discuss t…
States have begun to release their vaccine distribution plans, and President Trump and Biden spent the final debate sparring over…
Drug pricing continues to make the news, so we’re revisiting our conversation with Dr. Janet Woodcock of the FDA about bringing d…
President Trump’s apparent quick and successful battle with the COVID-19 virus should set the standard for care that all American…
The future of the Affordable Care Act is uncertain with a Supreme Court vacancy. Terry and Dr. Bob discuss protections for preexi…
Cancer research may yield a potential COVID-19 therapeutic. Dr. Bob interviews Dr. John Rothman of Tyme Technologies about the pr…
The finish line for the vaccine race is just around the corner. Terry and Dr. Bob react to vaccine developments and respond to IC…
Get an inside look into the drug supply chain and the factors that impact your bill at the pharmacy counter. Dr. Robert Popovian,…
In celebration of Labor Day, we look at a business that is empowering the chronic disease community. Kate interviews Keisha Greav…